Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fincham, R. W.
Right arrow Articles by Dunn, V. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fincham, R. W.
Right arrow Articles by Dunn, V. D.
NEUROLOGY 1985;35:720
© 1985 American Academy of Neurology

Bilateral focal Cortical atrophy and chronic ergotarnine abuse

Richard W. Fincham, MD, Zack Perdue, MD and Val D. Dunn, MD

Departments of Neurology (Drs. Fincham and Perdue) and Radiology (Dr. Dunn), University of Iowa College of Medicine, Iowa City, IA.

A 67-year-old patient took 5 mg of ergotamine daily for 18 months. His headaches and dysphoria were greatly improved by stopping this drug. Brain imaging by CT and magnetic resonance techniques showed numerous atrophic lesions that may represent infarcts due to occlusion of superficial cortical vessels.

Address correspondence and reprint requests to Dr. Fincham, Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242.

Accepted for publication August 29, 1984.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by AAN Enterprises, Inc.